Harold Smith Email & Phone Number

Rochester, Ny

As founder and CEO of OyaGen, Inc I coordinated a group of Ph.D. scientist in drug discovery for viral diseases and fee-for-service method development. The position also requires leadership in identifying grant funding opportunities, writing manuscripts, coordinating the company's patent estate and maintaining relationships with contract research organizations and collaborators, government and investor relationships and media.

Rochester, New York Area

Cannametrix, LLC is a testing lab with a strategic different approach for establishing new standards for quality control and efficacy of medicinal cannabis

Rochester, Ny Usa

1200 Jefferson Road, Rochester, Ny 14623

OyaGen: We are a biotech specializing in oral and injectable drug discovery and development for the treatment of viral infectious diseases (www.oyageninc.com). We focus on developing first in class or best in class antivirals. We have a lead compound that is a broad spectrum antiviral shown to be highly effective against COVID and Ebola and is predicted to be active against numerous unrelated virus. We have had our preIND meeting with the FDA have produced a significant quantity of cGMP API. Background on us and the lead are attached. We also have a lead the has curative potential for HIV that has been formulated for oral delivery. All of OyaGen’s leads have been published and patented.The company’s platform technology and pipeline has been developed over the 20 years the company has been in business.CannaMetrix, LLC is a family owned, private business that offers a testing platform for determining the potency of cannabis extracts, synthetic cannabinoids and terpenes, and blends of cannabinoids. Our goal is to address an industry wide unmet need for more relevant potency testing methods. CannaMetrix received a patent in October 2023 covering human cell-based potency testing as an industrial method for determining biological potency of cannabinoids. Products that are tested for the potency in human biology, their chemical composition analysis and toxic substance testing will inform product developers and consumers as to how major and minor cannabinoids may manifest their potency in the consumer. As a result, commercialization of products that have been validated by this next generation of testing will have greater market share through consumer confidence and product loyalty. CannaMetrix and its patent will disrupt the status quo of the cannabis industry and through improved product predictability, will ensure that the cannabis industry is not just a short term bubble. http://cannametrix.org

601 Elmwood Ave University Of Rochester Medical Center

As a full professor in the Department of Biochemistry and Biophysics, a am responsible for securing extramural funding for my research program and staffing working on APOBEC proteins and their editing of genetic information in healthy cells and disease states. I am also course director for a theory and laboratory course in in methods in biochemistry and critical thinking for biomedical science undergraduate majors at the U of Rochester. Publishing and presenting my research at international meetings is an annual pursuit in this occupation.

Ma, Ph.D., Cell/Cellular And Molecular Biology

Activities and Societies: Ph.D.. thesis research on liver regeneration and DNA replication/cell cycle analysisEvaluated DNA replication.

Education record